Japan’s Takeda agrees to $62 billion takeover of Shire
LONDON (Reuters) – Takeda Pharma agreed to buy London-listed Shire for 46 billion pounds ($62.42 billion) on Tuesday after the Japanese company raised the amount of cash in its offer to $30.33 to secure a recommendation.
